TurtleTree
TurtleTree (США/Сингапур) производит LF+ — по данным компании, первый в мире веганский лактоферрин, полученный прецизионной ферментацией. Лактоферрин — биоактивный белок молока, повышающий пищевую ценность продуктов питания, товаров для здоровья, косметики.
Профиль
TurtleTree is a private biotechnology company that uses precision fermentation to produce sustainable, animal-free lactoferrin (its LF+ / “Pink Gold™” ingredient) for food, beverages, early-life nutrition, and supplements; LF+ is FDA GRAS “No Questions/No Objection Letter”. It was founded in 2019 and is based in Singapore (HQ listed as 79 Ayer Rajah Crescent #05-03, Block 79, Singapore 139955). In July 2026, it signed an agreement with Novonesis for exclusive scaling/manufacturing/commercialization for early-life nutrition and received a minority investment from Novonesis plus 321Catalyst Ventures. TurtleTree is incorporated as TURTLETREE LABS PTE. LTD. and is Active. Reported employees: 18. Investors/funding disclosed: raised ~$39.4M total and has Series A; investors include VERSO Capital, KBW Ventures, Green Monday, Eat & Beyond Global, and others. Latest 2025–2026 developments: FDA “No Questions” GRAS letter in May 2025 and the Novonesis scaling/commercialization deal in July 2026; the company remains active.
Sources#
- TurtleTree | World’s First Sustainable Lactoferrin
- TurtleTree Secures FDA “No Questions” Letter for World’s First Precision-Fermented Lactoferrin — 2025-05-20
- TurtleTree - Products, Competitors, Financials, Employees, Headquarters Locations
- Novonesis and TurtleTree enter partnership to support commercialization of lactoferrin | Novonesis — 2026-07-08
- TURTLETREE LABS PTE. LTD. - 2026 Company Profile - Tracxn — 2026-02-04
- TurtleTree 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- TurtleTree — 2026-06-27
- TurtleTree, Novonesis partner on precision-fermented lactoferrin — 2026-07-08
- Отрасль
- Альтернативные белки, Косметика, Оборудование для биопроизводства, Пищевые ингредиенты
- Темы
- Прецизионная ферментация (белки, молоко, яйцо), Растительные мясо, молоко и яйцо, Гиалуроновая кислота, коллаген и активные вещества для косметики
- Роль
- Производитель — “…nesis for exclusive scaling/manufacturing/commercialization for early-life nutrition and received a minority i…”
Биорешения, которые поставляет 0
Пока не указана поставщиком в решениях с доказательствами.
Что предлагают
Компания не публикует продукты и услуги — узнаем через знакомство.
Новости и статус 6
- 2026-07 Последний статус: TurtleTree заключила эксклюзивное партнёрство с Novonesis и получила от неё миноритарные инвестиции для масштабирования, производства и продаж лактоферрина LF+. ↗ ↗ ↗
- 2026-07-16 Novonesis and TurtleTree enter partnership to support commercialization of lactoferrinTurtleTree is a precision fermentation company that has developed LF+®, a lactoferrin product for early life nutrition and dietary supplements, and is the first to receive US FDA GRAS status for precision-fermented lactoferrin. The company partnered with …
- 2026-07-08 TurtleTree, Novonesis partner on precision-fermented lactoferrinTurtleTree, shifting from cell-cultured milk to a precision fermentation platform, is partnering with Novonesis (with participation from Mitsui’s 321Catalyst) to scale lactoferrin production and move toward food-scale manufacturing, supported by a minority …
- 2026-09-07 TurtleTree turns FDA-Cleared Lactoferrin into a scale-up bet with NovonesisTurtleTree has achieved a major milestone by securing FDA GRAS clearance for precision-fermented lactoferrin (LF+) and partnering with Novonesis to scale, manufacture, and commercialize LF+ for early life nutrition. The deal positions TurtleTree to move from …
- 2026-07-08 TurtleTree bags new capital to scale lactoferrin outputTurtleTree has raised new funding from Novonesis and Mitsui Chemicals to accelerate commercialization, manufacturing efficiency, and global expansion of its animal-free lactoferrin products, including its IronKind brand, with plans to enter dietary supplements …
- 2026-07-07 TurtleTree Labs Pte. Ltd. announced that it has received funding from 321Catalyst Ventures, Inc., Novozymes A/S | MarketScreenerTurtleTree Labs Pte. Ltd. announced that it has received funding from 321Catalyst Ventures, Inc. and Novozymes A/S. The investment involves convertible preferred shares as part of a funding round.
- 2026-09-29 Turtle Tree labs a biotech firm develops milk without cows using cells based technology - Dairy News 7x7TurtleTree Labs is a Singapore-based biotech startup developing milk made from mammalian cells instead of cows, aiming to replicate regular milk’s composition and taste while addressing sustainability concerns. The company has attracted significant funding and …
Связи: владельцы, партнёры, аналоги
Владельцы и инвесторы 1
| инвестор | Novonesis |
Партнёры и сделки 1
| сторона сделки | Novonesis …TurtleTree entered into an exclusive partnership and received a minority investment from Novonesis to scale, manufacture, and commercialize its precision-fermented lactoferrin (LF+).… |
Похожие компании
SYNAURA Biotech · Laurus Bio · Glac Biotech Co., Ltd. · bereum Co., Ltd · Sanzyme Biologics · New Bellus · Yakult Honsha Co., Ltd. · CABIO BIOTECH
Реквизиты и контакты
Контакты, руководители и юридические данные доступны участникам.
Войти как участник